The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)
机构：[1]Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University华中科技大学同济医学院附属协和医院中山大学附属第三医院[2]Department of Infectious Diseases, Wuhan Union Hospital华中科技大学同济医学院附属协和医院[3]Department of Hepatology, Zhongshan Second People’s Hospital[4]Department of Infectious Diseases, First Affiliated Hospital of Kunming Medical University医技科室医学影像中心CT室昆明医科大学附属第一医院[5]Department of Hepatology, Guangzhou Eighth People’s Hospital[6]Department of Infectious Diseases, Foshan First People’s Hospital
第一作者机构：[1]Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University
推荐引用方式(GB/T 7714)：
Gao Zhiliang,Zhu Xiang,Lin Bingliang,et al.The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)[J].HEPATOLOGY.2018,68:246A-246A.doi:10.1002/hep.30257.
APA：
Gao, Zhiliang,Zhu, Xiang,Lin, Bingliang,Yi, Jianhua,Gao, Wenjun...&Zhao, Qiyi.(2018).The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study).HEPATOLOGY,68,
MLA：
Gao, Zhiliang,et al."The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)".HEPATOLOGY 68.(2018):246A-246A
医学